Ads
related to: sluggish cognitive tempo disorder symptoms
Search results
Results From The WOW.Com Content Network
In April 2014, The New York Times reported that sluggish cognitive tempo is the subject of pharmaceutical company clinical drug trials, including ones by Eli Lilly that proposed that one of its biggest-selling drugs, Strattera, could be prescribed to treat proposed symptoms of sluggish cognitive tempo. [57]
Bradyphrenia is the slowness of thought common to many disorders of the brain. [1] ... Several symptoms listed included decreased ... Sluggish cognitive tempo; References
The emerging concept of sluggish cognitive tempo has also been implicated in the expression of brain fog symptoms. [42] Patients recovering from COVID-19 report experiencing brain fog, which can reflect a wide variety of neurological and psychological symptoms linked to COVID-19. [43]
As of April 14th, 2014, the statement under SCT under History that "As of April 2014, sluggish cognitive tempo is the subject of pharmaceutical company clinical drug trials, including ones by Eli Lilly that proposed that Strattera could be prescribed to treat proposed symptoms of sluggish cognitive tempo.[4]" is false.
To put that in perspective, two of the newer medications, lecanemab and donanemab, have been shown to moderately slow a decline in memory and thinking abilities — by 27.1% and 22.3% ...
Cognitive Tempo (a term of cognitive psychology, ... Sluggish cognitive tempo (SCT) References. Works. Development of Cognitive Tempo; Galotti, K. (2008). "Cognitive ...
Ad
related to: sluggish cognitive tempo disorder symptoms